↓ Skip to main content

Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, April 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users
googleplus
1 Google+ user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years
Published in
ClinicoEconomics and Outcomes Research: CEOR, April 2014
DOI 10.2147/ceor.s57904
Pubmed ID
Authors

Andreas Karabis, Michelle Mocarski, Indra Eijgelshoven, Gert Bergman

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Germany 1 2%
Unknown 51 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 28%
Student > Master 11 21%
Student > Bachelor 6 11%
Other 4 8%
Student > Postgraduate 4 8%
Other 9 17%
Unknown 4 8%
Readers by discipline Count As %
Medicine and Dentistry 22 42%
Economics, Econometrics and Finance 8 15%
Nursing and Health Professions 4 8%
Agricultural and Biological Sciences 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Other 7 13%
Unknown 4 8%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#7,099,717
of 25,864,668 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#141
of 527 outputs
Outputs of similar age
#62,368
of 240,138 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#7
of 16 outputs
Altmetric has tracked 25,864,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.